| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |